Status:
COMPLETED
Presepsin as a Predictor for Postoperative Complications Following Pancreatic Resection
Lead Sponsor:
Medical University Innsbruck
Conditions:
Postoperative Complications
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The study investigates the local and systemic inflammatory response following pancreatic resections.
Detailed Description
Pancreatic resections (PR) are major hepato-pancreatico-biliary (HPB) surgeries associated with significant morbidity and mortality. Despite improvements in surgical technique, as well as peri- and po...
Eligibility Criteria
Inclusion
- Patients with any pancreatic pathology (benign and malign) requiring surgery
- Written informed consent
- \>= 18 years
Exclusion
- Pregnancy
- Patients who are not capable of giving informed consent (e.g. with existing medical trustee)
Key Trial Info
Start Date :
July 11 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
86 Patients enrolled
Trial Details
Trial ID
NCT04294797
Start Date
July 11 2017
End Date
December 31 2019
Last Update
March 4 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of Innsbruck
Innsbruck, Tyrol, Austria, 6020